• LAST PRICE
    213.9000
  • TODAY'S CHANGE (%)
    Trending Down-2.3100 (-1.0684%)
  • Bid / Lots
    211.0000/ 1
  • Ask / Lots
    225.0000/ 1
  • Open / Previous Close
    219.0800 / 216.2100
  • Day Range
    Low 210.6550
    High 219.0800
  • 52 Week Range
    Low 119.7604
    High 299.9800
  • Volume
    278,074
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 216.21
TimeVolumeMDGL
09:32 ET1744216.93
09:34 ET480215.46
09:38 ET450218.4597
09:41 ET100216.9
09:45 ET2200217.39
09:50 ET256216.635
09:52 ET200215.77
09:54 ET100216
09:56 ET150216
09:57 ET1324214.6
09:59 ET1213214.685
10:01 ET1276216.165
10:03 ET524215.33
10:06 ET1102215.97
10:10 ET300214.755
10:14 ET500215.03
10:15 ET200214.47
10:17 ET800214.41
10:19 ET981214.875
10:24 ET100214.925
10:26 ET100214.945
10:30 ET300214.27
10:35 ET244214.45
10:37 ET800214.71
10:42 ET100214.0001
10:50 ET1388213.815
10:55 ET1300212.99
10:57 ET200212.9194
11:00 ET1100211.6
11:02 ET300211.6628
11:04 ET400212.22
11:06 ET200212.63
11:08 ET500213.17
11:09 ET200213.31
11:11 ET111213.94
11:13 ET787214.32
11:15 ET200214.39
11:18 ET409213.995
11:20 ET149214.074
11:27 ET200214.1442
11:31 ET100214.52
11:33 ET100214.57
11:38 ET200214.6833
11:42 ET6523213.96
11:44 ET100214.17
11:45 ET200213.51
11:47 ET100214.28
12:03 ET100213.8
12:05 ET253213.82
12:07 ET100214.01
12:18 ET100213.37
12:23 ET3325212.39
12:25 ET600212.49
12:27 ET2126212.82
12:32 ET110212.6601
12:38 ET925212.5
12:39 ET500212.815
12:43 ET100212.76
12:50 ET100213.48
12:52 ET100212.8101
12:57 ET200213.09
01:01 ET224213.205
01:10 ET290212.8
01:15 ET400211.8
01:17 ET200211.97
01:19 ET200212.11
01:26 ET250211.96
01:30 ET1800211.375
01:32 ET400211.435
01:42 ET200211.285
01:46 ET400211
01:48 ET400210.945
01:50 ET620210.945
01:51 ET1223211.405
01:53 ET150211.125
01:55 ET700211
01:57 ET281211.5187
02:00 ET100211.58
02:02 ET349211.91
02:04 ET477211.57
02:06 ET100210.775
02:09 ET2300211.095
02:11 ET2200210.96
02:13 ET500211.15
02:15 ET300211.68
02:18 ET985211.69
02:22 ET400211.75
02:26 ET450211.82
02:29 ET200211.825
02:33 ET204211.871
02:36 ET200211.925
02:38 ET100211.98
02:40 ET1200212.005
02:42 ET100212.13
02:44 ET100212.405
02:47 ET700212.18
02:51 ET200211.97
02:54 ET3798213.17
02:56 ET100213.5
03:00 ET1750212.85
03:03 ET200213.275
03:05 ET100213.265
03:07 ET100213.51
03:12 ET500213.93
03:18 ET1308213.555
03:20 ET203214.31
03:21 ET100213.95
03:23 ET700214.065
03:25 ET138213.81
03:27 ET100213.95
03:30 ET1329214.02
03:32 ET2250214.34
03:36 ET400214.185
03:38 ET458213.71
03:39 ET1810213.93
03:43 ET570213.8
03:45 ET300213.255
03:48 ET1500213.82
03:50 ET100213.67
03:52 ET1085213.745
03:54 ET200213.77
03:56 ET18771214.09
03:57 ET3808213.685
03:59 ET56591213.9
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMDGL
Madrigal Pharmaceuticals Inc
4.7B
-8.4x
---
United StatesBHVN
Biohaven Ltd
4.7B
-5.6x
---
United StatesBBIO
BridgeBio Pharma Inc
4.6B
-9.3x
---
United StatesIMVT
Immunovant Inc
4.2B
-14.8x
---
United StatesCRNX
Crinetics Pharmaceuticals Inc
4.0B
-13.4x
---
United StatesRNA
Avidity Biosciences Inc
5.4B
-14.3x
---
As of 2024-09-26

Company Information

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.

Contact Information

Headquarters
200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
Phone
404-380-9263
Fax
302-655-5049

Executives

Independent Chairman of the Board
Julian Baker
President, Chief Executive Officer, Director
Bill Sibold
Chief Financial Officer, Senior Vice President
Mardi Dier
President of Research and Development, Chief Medical Officer, Director
Rebecca Taub
General Counsel
Shannon Kelley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.7B
Revenue (TTM)
$14.6M
Shares Outstanding
21.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.44
EPS
$-25.50
Book Value
$20.39
P/E Ratio
-8.4x
Price/Sales (TTM)
320.7
Price/Cash Flow (TTM)
---
Operating Margin
-3,622.65%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.